Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings Inc (NQ: HRMY )

36.44 -0.01 (-0.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 402,729
Open 36.50
Bid (Size) 35.00 (1)
Ask (Size) 37.92 (1)
Prev. Close 36.45
Today's Range 35.61 - 36.69
52wk Range 29.81 - 62.09
Shares Outstanding 59,954,618
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Harmony Biosciences Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Analyst Expectations for Harmony Biosciences's Future
 
Via Benzinga

Performance

YTD
-31.19%
-31.19%
1 Month
+1.08%
+1.08%
3 Month
-15.96%
-15.96%
6 Month
-39.29%
-39.29%
1 Year
-19.91%
-19.91%

More News

Read More
Harmony Biosciences (HRMY) Q1 2023 Earnings Call Transcript
Via The Motley Fool
Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
Earnings Outlook For Harmony Biosciences
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Analyst Ratings for Harmony Biosciences
Via Benzinga
Where Harmony Biosciences Stands With Analysts
Via Benzinga
Why Shares of Harmony Bioscience Are Slumping Tuesday
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
Via Benzinga
7 Stocks to Buy to Bag Big-Time Returns in Q2
Via InvestorPlace
NASDAQ:HRMY Shareholder Alert: Investigation over Possible Securities Laws Violations by Harmony Biosciences Holdings, Inc.
Via SBWire
Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Novavax Outlook: Why NVAX Stock Could 12X in the Next 12 Months
Via InvestorPlace
7 Biotech Stocks to Buy for 100% Returns
Via InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Nutanix and Harmony and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Harmony Biosciences Holdings, Inc. (HRMY) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Harmony Biosciences Holdings, Inc. (HRMY) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
HARMONY ALERT: Bragar Eagel & Squire, P.C. is Investigating Harmony Biosciences Holdings, Inc. on Behalf of Harmony Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Harmony Biosciences Holdings, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Harmony Biosciences Holdings, Inc. (HRMY) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Lost Money in Harmony Biosciences Holdings Inc.?
From Gibbs Law Group
Via Business Wire
Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Harmony Biosciences Holdings, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Harmony Biosciences Holdings, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – HRMY
From The Rosen Law Firm, P.A.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.